“Off-label”: what it means to be prescribed Ozempic without an approved indication

(First: this is general health education, not medical advice.)

According to reporting by Gizmodo, more than a million people in the United States have been prescribed a GLP-1 without an FDA-approved indication. I'm citing the figure with its source because I did not verify it myself; nothing below depends on it.

The word that matters is "off-label." And the first thing to say is the thing almost nobody says.

"Off-label" is not illegal, not rare, and not a scandal

Off-label prescribing is a normal, legal part of medicine. It happens every day, in every specialty — sometimes because the evidence moved faster than the approval paperwork, sometimes because the trial in that particular group of patients was never run. A physician can legitimately use a drug for something not on the label when clinical judgement supports it.

So if someone told you "off-label" means you were scammed, they were wrong. And if someone told you it doesn't matter at all, they were wrong too.

The dividing line isn't the label. It's supervision

This is the whole point of the article.

An off-label prescription can be careful medicine or it can be a transaction. What separates them is not the drug's approval status: it's whether a professional evaluated you and is still watching.

Careful medicine looks like this: someone took your history, reviewed what else you take, ordered the tests that were warranted, explained the side effects and what to do about them, set a follow-up date, and there is a number you call if something goes wrong.

A transaction looks like this: you filled in a form on a website, nobody examined you, nobody asked about your other medications, a box arrived, and there is nobody behind it.

Same drug. Same dose. Two situations with nothing in common.

The questions that tip the balance back to you

If you're being prescribed a GLP-1 — approved indication or not — these are the questions. None of them is rude; a good clinician welcomes them:

1. What are you prescribing this for, and is that within the approved indication? If it's outside, that's a legitimate answer. What you want to hear is why.
2. What did you check before prescribing it? History, current medications, labs, the personal and family history that matters.
3. Which side effects are expected, and which are urgent? And how to tell them apart.
4. When do we meet again, and what will we measure?
5. Who do I call if something goes wrong on a Sunday? If there's no answer to this one, there is no supervision.
6. What happens when I stop? A conversation worth having before, not after.

And the part I can't stay quiet about as a physician

A GLP-1 is not a supplement. It affects blood sugar, stomach emptying and appetite; it interacts with other medications; and its side effects range from annoying to serious. That doesn't make it a bad drug — it's a genuinely useful tool for the right people. It makes it a drug that needs someone watching.

Which is why the channel matters as much as the prescription: where you buy it is not an administrative detail. A product with no real prescriber behind it has no supervision by definition, however correct the label on the vial.

The honest summary

"It's approved" does not mean "it's safe for you." "It's off-label" does not mean "you're being conned." Both sentences are noise if nobody is watching you.

The useful question — the one that protects you in either case — is: who evaluated me, what did they check, and who do I call if something goes wrong?

That's Amor Consciente applied to a prescription: not fear of the medication, not blind faith in it. An informed adult, accompanied by someone who answers the phone.

(General education, not medical advice, and not an opinion about your treatment. Do not start, stop or change any medication or its dose on your own. If you live with diabetes, prediabetes or another condition, or you take other drugs, that conversation belongs with your doctor or prescriber.)